NCT05597774

Brief Summary

The main objective of the present study is to observe the short-term effects of respiratory muscle training combined with an exercise training program on quality of life and exercise tolerance in individuals with long-term post-COVID-19 symptoms. As secondary objectives, the effects on respiratory muscle function, physical and lung function, as well as on the psychological state of these individuals.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
64

participants targeted

Target at P25-P50 for not_applicable covid19

Timeline
Completed

Started Oct 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 7, 2022

Completed
21 days until next milestone

First Posted

Study publicly available on registry

October 28, 2022

Completed
Same day until next milestone

Study Start

First participant enrolled

October 28, 2022

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 22, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 22, 2023

Completed
Last Updated

September 28, 2023

Status Verified

September 1, 2022

Enrollment Period

11 months

First QC Date

October 7, 2022

Last Update Submit

September 27, 2023

Conditions

Keywords

Respiratory Muscle TrainingTele-rehabilitationQuality of LifeExercise

Outcome Measures

Primary Outcomes (2)

  • Change in quality of life

    Change in quality of life between baseline and post-intervention, as measured by the EuroQol-5D questionnaire which consists of 5 dimensions with 5 response options based on severity level, ranging from 1 to 5. An index score is provided, ranging from 0 (death) to 1 (full health).

    Baseline and 1-week post-intervention (9 weeks from baseline)

  • Change in exercise tolerance

    Change in exercise tolerance between baseline and post-intervention, as measured by a cardiopulmonary exercise test

    Baseline and 1-week post-intervention (9 weeks from baseline)

Secondary Outcomes (4)

  • Change in respiratory muscle function

    Baseline and 1-week post-intervention (9 weeks from baseline)

  • Change in physical function

    Baseline and 1-week post-intervention (9 weeks from baseline)

  • Change in pulmonary function

    Baseline and 1-week post-intervention (9 weeks from baseline)

  • Change in psychological status

    Baseline and 1-week post-intervention (9 weeks from baseline)

Study Arms (2)

Exercise training + Inspiratory and expiratory muscle training group

EXPERIMENTAL

Participants will perform a cardiovascular exercise program 2 days per week during 8 weeks in the hospital, combined with an inspiratory and expiratory muscle training by a threshold device at home, twice a day, 3 days per week, for 8 weeks supervised by a physiotherapist through a virtual platform.

Other: Inspiratory + expiratory muscle training groupOther: Exercise training program

Exercise training + Inspiratory and expiratory muscle training sham group

SHAM COMPARATOR

Participants will perform a cardiovascular exercise program 2 days per week during 8 weeks in the hospital, combined with an inspiratory and expiratory muscle training by a sham threshold device at home, twice a day, 3 days per week, for 8 weeks supervised by a physiotherapist through a virtual platform.

Other: Inspiratory + expiratory muscle training sham groupOther: Exercise training program

Interventions

Participants will perform an inspiratory and expiratory muscle training including warm-up, recovery between intervals and return to calm.

Exercise training + Inspiratory and expiratory muscle training group

Participants will perform an inspiratory and expiratory muscle training including warm-up, recovery between intervals and return to calm.

Exercise training + Inspiratory and expiratory muscle training sham group

Participants will perform a cardiovascular exercise program including warm-up, recovery between intervals and return to calm by cycloergometer.

Exercise training + Inspiratory and expiratory muscle training groupExercise training + Inspiratory and expiratory muscle training sham group

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Over 18 years who presented long-term post-COVID-19 symptoms of fatigue and dyspnoea for at least 3 months after the COVID-19 diagnosis

You may not qualify if:

  • Progressive respiratory, neuromuscular or neurological disorders and/or psychiatric or cognitive conditions that hindered their ability to cooperate
  • Comorbidity that could interfere with the study interventions
  • Any contraindication to the training interventions

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital Universitario 12 de Octubre de Madrid

Madrid, 28041, Spain

Location

Related Publications (3)

  • McNarry MA, Berg RMG, Shelley J, Hudson J, Saynor ZL, Duckers J, Lewis K, Davies GA, Mackintosh KA. Inspiratory muscle training enhances recovery post-COVID-19: a randomised controlled trial. Eur Respir J. 2022 Oct 6;60(4):2103101. doi: 10.1183/13993003.03101-2021. Print 2022 Oct.

    PMID: 35236727BACKGROUND
  • Nopp S, Moik F, Klok FA, Gattinger D, Petrovic M, Vonbank K, Koczulla AR, Ay C, Zwick RH. Outpatient Pulmonary Rehabilitation in Patients with Long COVID Improves Exercise Capacity, Functional Status, Dyspnea, Fatigue, and Quality of Life. Respiration. 2022;101(6):593-601. doi: 10.1159/000522118. Epub 2022 Feb 24.

    PMID: 35203084BACKGROUND
  • Del Corral T, Fabero-Garrido R, Plaza-Manzano G, Izquierdo-Garcia J, Lopez-Saez M, Garcia-Garcia R, Lopez-de-Uralde-Villanueva I. Effect of respiratory rehabilitation on quality of life in individuals with post-COVID-19 symptoms: A randomised controlled trial. Ann Phys Rehabil Med. 2025 Feb;68(1):101920. doi: 10.1016/j.rehab.2024.101920. Epub 2025 Jan 11.

MeSH Terms

Conditions

COVID-19Post-Acute COVID-19 SyndromeMotor Activity

Interventions

Inhalation

Condition Hierarchy (Ancestors)

Pneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract DiseasesPost-Infectious DisordersChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsBehavior

Intervention Hierarchy (Ancestors)

Respiratory MechanicsRespirationRespiratory Physiological PhenomenaCirculatory and Respiratory Physiological Phenomena

Study Officials

  • Ibai López de Uralde, PhD

    Universidad Complutense de Madrid

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 7, 2022

First Posted

October 28, 2022

Study Start

October 28, 2022

Primary Completion

September 22, 2023

Study Completion

September 22, 2023

Last Updated

September 28, 2023

Record last verified: 2022-09

Data Sharing

IPD Sharing
Will not share

Locations